Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Gates Capital Management Reveals New 5.1% Stake In USG Corporation (USG)

Jeffrey Gates believes it is a good time to buy USG Corporation (NYSE:USG) and has initiated a position for his fund, Gates Capital Management. As reported in a recent filing with the Securities and Exchange Commission, Gates Capital has bought a little under 7 million shares of USG Corporation (NYSE:USG), which account for 5.1% of the total number of shares outstanding.

USG Corporation (NYSE:USG)

The fact that legendary investor Warren Buffett holds a massive stake in USG Corporation (NYSE:USG) is an important factor. In its latest 13F filing, Berkshire Hathaway has reported ownership of 34.9 million shares, having made no changes to the position during the first quarter of 2014. David E. Shaw is also a fan of this stock, having increased his fund’s stake by 17% during the same period of time. D E Shaw reportedly holds 1.24 million shares of USG Corporation (NYSE:USG). Phill Gross and Robert Atchinson have, on the other hand, chosen to halve their holding of the stock, leaving their fund, Adage Capital Management, with 1.22 million shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!